About Boyds
A global drug development consultancy helping biotech, pharma and medical device companies bring innovative therapies to patients faster.
Boyds is a dynamic and rapidly growing global drug development consultancy focused on providing specialist consultancy services to an international client base, supporting the development of new, cutting-edge medicines for patient benefit.
Years supporting global drug development
Clients supported across the globe
Cell & gene therapies approved with Boyds’ support
Client satisfaction rate
Working with pharma companies, early-stage biotechs, medical device companies and universities, the team supports the development of cell and gene therapies, small molecules, biologics and orphan drugs across a wide range of therapeutic areas.
The team has expertise in program management and product development, pharmaceutical due diligence, clinical operations, medical monitoring, regulatory affairs and strategy, medical writing, regulatory operations and provides scientific and medical advice to facilitate the translation of ideas into medicines.
The company was founded in 2005 by Professor Alan Boyd and now has offices in Pennsylvania, Cambridge, Crewe, and Dublin. In 2018, Boyds was awarded the prestigious Queen’s Award for Enterprise, International Trade in recognition for its international work, and in particular its support in the development of gene therapies for the treatment of rare diseases.
Explore Boyds
Speak with a Drug Development Expert
Need support with:
- Regulatory strategy
- Clinical development
- Due diligence
- CMC
- Medical affairs
- Regulatory Submission Management
Get in touch today.
Get in touch
If you would like to talk to a member of our team about a specific project or area of expertise, then please complete this form and we will get in touch.